Literature DB >> 15978945

Retroviral expression screening of oncogenes in natural killer cell leukemia.

Young Lim Choi1, Ryozo Moriuchi, Mitsujiro Osawa, Atsushi Iwama, Hideki Makishima, Tomoaki Wada, Hiroyuki Kisanuki, Ruri Kaneda, Jun Ota, Koji Koinuma, Madoka Ishikawa, Shuji Takada, Yoshihiro Yamashita, Kazuo Oshimi, Hiroyuki Mano.   

Abstract

Aggressive natural killer cell leukemia (ANKL) is an intractable malignancy that is characterized by the outgrowth of NK cells. To identify transforming genes in ANKL, we constructed a retroviral cDNA expression library from an ANKL cell line KHYG-1. Infection of 3T3 cells with recombinant retroviruses yielded 33 transformed foci. Nucleotide sequencing of the DNA inserts recovered from these foci revealed that 31 of them encoded KRAS2 with a glycine-to-alanine mutation at codon 12. Mutation-specific PCR analysis indicated that the KRAS mutation was present only in KHYG-1 cells, not in another ANKL cell line or in clinical specimens (n=8).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978945     DOI: 10.1016/j.leukres.2005.02.002

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma.

Authors:  Tao Fu; Angela A Guzzetta; Jana Jeschke; Rajita Vatapalli; Pujan Dave; Craig M Hooker; Richard Morgan; Christine A Iacobuzio-Donahue; Baohua Liu; Nita Ahuja
Journal:  Int J Cancer       Date:  2013-01-18       Impact factor: 7.396

2.  Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.

Authors:  Chia-Lin Chen; Hidekazu Tsukamoto; Jian-Chang Liu; Claudine Kashiwabara; Douglas Feldman; Linda Sher; Steven Dooley; Samuel W French; Lopa Mishra; Lydia Petrovic; Joseph H Jeong; Keigo Machida
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

3.  Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality.

Authors:  Paloma Bárcena; María Jara-Acevedo; María Dolores Tabernero; Antonio López; María Luz Sánchez; Andrés C García-Montero; Noemí Muñoz-García; María Belén Vidriales; Artur Paiva; Quentin Lecrevisse; Margarida Lima; Anton W Langerak; Sebastian Böttcher; Jacques J M van Dongen; Alberto Orfao; Julia Almeida
Journal:  Oncotarget       Date:  2015-12-15

4.  Involvement of KRAS G12A mutation in the IL-2-independent growth of a human T-LGL leukemia cell line, PLT-2.

Authors:  Naoki Mizutani; Hiromi Ito; Kazumi Hagiwara; Misa Kobayashi; Asuka Hoshikawa; Yayoi Nishida; Akira Takagi; Tetsuhito Kojima; Motoshi Suzuki; Yosuke Osawa; Kazunori Ohnishi; Masanori Daibata; Takashi Murate
Journal:  Nagoya J Med Sci       Date:  2012-08       Impact factor: 1.131

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.